10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34481934 | Vorinostat triggers miR-769-5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer. | 2021 Sep 3 | 1 |
2 | 33194023 | ΔNp63α promotes the expression and nuclear translocation of PTEN, leading to cisplatin resistance in oral cancer cells. | 2020 | 1 |
3 | 27065869 | Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells. | 2016 | 2 |
4 | 27069638 | Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells. | 2016 Apr | 1 |
5 | 24864038 | Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors. | 2014 Jul 15 | 1 |
6 | 24189584 | Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells. | 2013 Nov 28 | 1 |
7 | 22036991 | Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents. | 2011 Dec 15 | 1 |
8 | 20460513 | Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage. | 2010 Jun 1 | 1 |
9 | 17671692 | The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. | 2007 Sep | 1 |
10 | 15583844 | The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines. | 2005 Jan | 4 |